Results 241 to 250 of about 24,619 (304)

XFM and HERFD-XAS studies of selenium in tissues and whole blood from mice supplemented with potentially therapeutic selenocompounds. [PDF]

open access: yesRedox Rep
Baker AT   +11 more
europepmc   +1 more source

Engineered Carbon Dots as Multifunctional Nanoplatforms for Next‐Generation High‐Performance Advanced Batteries

open access: yesCarbon Energy, EarlyView.
Herein, we mainly summarize the characteristics of the main types of carbon dots (CDs), analyze the strategies for improving advanced batteries' performance via incorporating CDs, comprehensively summarize recent applications of CDs in the main components (electrode, electrolyte, and separator) of advanced batteries, and propose the technical ...
Chuang Jiang   +5 more
wiley   +1 more source

Spectroscopic Fingerprinting of Coordination-driven Spin States in Metal-organic Architectures. [PDF]

open access: yesChemistry
Grisan Qiu YY   +10 more
europepmc   +1 more source

Emergence of unconventional ferroelectric phase in ultrathin Hf<sub>0.5</sub>Zr<sub>0.5</sub>O<sub>2</sub> films. [PDF]

open access: yesSci Adv
Lee S   +14 more
europepmc   +1 more source

NaFeNb(PO<sub>4</sub>)<sub>3</sub> as an Electrode Material for Sodium-Ion Batteries: Insights into Phase Evolution and Capacity Fading. [PDF]

open access: yesChem Mater
Pianta N   +13 more
europepmc   +1 more source

Ouma Geelmeid ke kx’u //xa//xa N/uu

open access: yes, 2016
Shah, Sheena, Brenzinger, Matthias
openaire  

An edge with XAS

Nature Structural Biology, 1998
X-ray absorption spectroscopy, which relies on synchrotron radiation, can accurately determine aspects of metalloprotein active site structure, can be applied to solution or crystalline samples and can be used independently or to supplement crystallographic information.
G N, George, B, Hedman, K O, Hodgson
openaire   +2 more sources

Oral Xa Inhibitors

Hematology/Oncology Clinics of North America, 2010
Several new oral drugs that selectively and directly inhibit factor Xa seem promising alternatives to existing antithrombotic drugs. These drugs have a convenient route of administration, can be given in fixed doses, and do not require coagulation monitoring.
Romualdi E, AGENO, WALTER
openaire   +2 more sources

Home - About - Disclaimer - Privacy